586 results on '"Bougnoux, Marie‐Elisabeth"'
Search Results
2. Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases
3. Secretion of the fungal toxin candidalysin is dependent on conserved precursor peptide sequences
4. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme
5. Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study
6. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)
7. Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient
8. Prolonged Remission of Azole-Resistant Lung Aspergillosis with Olorofim, in an Adolescent with X-Linked Chronic Granulomatous Disease
9. The pathogenic and colonization potential of Candida africana
10. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome
11. Metagenomics and metabolomics approaches in the study of Candida albicans colonization of host niches: a framework for finding microbiome-based antifungal strategies
12. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases
13. The Role of Olorofim in the Treatment of Filamentous Fungal Infections: A Review of In Vitro and In Vivo Studies
14. Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study
15. Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with Acalabrutinib—findings from three cases
16. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
17. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa
18. Arthritis Caused by Nannizziopsis obscura, France
19. A gain-of-function mutation in zinc cluster transcription factor Rob1 Drives Candida albicans adaptive growth in the cystic fibrosis lung environment
20. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)
21. A CO 2 sensing module modulates β-1,3-glucan exposure in Candida albicans
22. Drug–drug interaction and inadequate exposure to voriconazole in critically ill patients with multiple organ failure: A pediatric case study
23. Tracing the Origin of Invasive Fungal Infections
24. Deep cutaneous mycoses in kidney transplant recipients: Diagnostic and therapeutic challenges
25. Unveiling Candida albicans intestinal carriage in healthy volunteers: the role of micro- and mycobiota, diet, host genetics and immune response
26. Reduced splenic function can mimic artemisinin resistance in severe malaria
27. Improving Diagnosis of Pulmonary Mucormycosis
28. Gradient concentration strip–specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes
29. Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency
30. Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.
31. Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)–Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France.
32. The pathogenic and colonization potential of Candida africana
33. Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network
34. Genome Diversity and Dynamics in Candida albicans
35. A conserved regulator controls asexual sporulation in the fungal pathogen Candida albicans
36. (1-3)-ß-D-glucan for the diagnosis of Nocardia infection in solid organ transplant recipients
37. Aspergillus felis in Patient with Chronic Granulomatous Disease
38. Case series of intestinal microsporidiosis in non-HIV patients caused by Encephalitozoon hellem.
39. Candida albicans Adhesion Measured by Optical Nanomotion Detection.
40. Comparing genomic variant identification protocols for Candida auris
41. Perturbation and resilience of the gut microbiome up to three months after β-lactams exposure in healthy volunteers suggest an important role of endogenous β-lactamases
42. Invasive bone and joint infections from the French Scedosporiosis/lomentosporiosis Observational Study (SOS) cohort: no mortality with long-term antifungal treatment and surgery
43. Comparing genomic variant identification protocols for Candida auris
44. Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review
45. Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis
46. Within-Host Genomic Diversity of Candida albicans in Healthy Carriers
47. Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention
48. Candida albicans bloodstream isolates in a German university hospital are genetically heterogenous and susceptible to commonly used antifungals
49. Le mycobiome humain : actualités et perspectives
50. A Clinical Study Provides the First Direct Evidence That Interindividual Variations in Fecal β-Lactamase Activity Affect the Gut Mycobiota Dynamics in Response to β-Lactam Antibiotics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.